ArticleMolecular cancer therapeutics2015

CD30 Downregulation, MMAE Resistance, and MDR1 Upregulation Are All Associated with Resistance to Brentuximab Vedotin.

Robert Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.